Both POLG and MAP2K7 exhibited low expression in AA, MDS, and AML, with significant inter-group differences observed among the diseases (Table 3, Supplementary Table S5-Verification, Figures 7A-C), which was consistent with bioinformatic predictions. The gene discussed is MAP2K7; the disease is myelodysplastic syndrome.